These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10023971)

  • 1. ECASS II: intravenous alteplase in acute ischaemic stroke. European Co-operative Acute Stroke Study-II.
    Barer D
    Lancet; 1999 Jan; 353(9146):66-7; author reply 67-8. PubMed ID: 10023971
    [No Abstract]   [Full Text] [Related]  

  • 2. ECASS-II: intravenous alteplase in acute ischaemic stroke. European Co-operative Acute Stroke Study-II.
    Ford G; Freemantle N
    Lancet; 1999 Jan; 353(9146):65; author reply 67-8. PubMed ID: 10023968
    [No Abstract]   [Full Text] [Related]  

  • 3. ECASS-II: intravenous alteplase in acute ischaemic stroke. European Co-operative Acute Stroke Study-II.
    Raha S
    Lancet; 1999 Jan; 353(9146):66; author reply 67-8. PubMed ID: 10023970
    [No Abstract]   [Full Text] [Related]  

  • 4. ECASS-II: intravenous alteplase in acute ischaemic stroke. European Co-operative Acute Stroke Study-II.
    Lees KR
    Lancet; 1999 Jan; 353(9146):65-6; author reply 67-8. PubMed ID: 10023969
    [No Abstract]   [Full Text] [Related]  

  • 5. ECASS-II: intravenous alteplase in acute ischaemic stroke. European Co-operative Acute Stroke Study-II.
    Jenkinson D
    Lancet; 1999 Jan; 353(9146):67-8. PubMed ID: 10023972
    [No Abstract]   [Full Text] [Related]  

  • 6. Alteplase for thrombolysis in acute ischemic stroke.
    Med Lett Drugs Ther; 1996 Nov; 38(987):99-100. PubMed ID: 8914507
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombolysis in stroke--results of the ECASS study (European Cooperative Acute Stroke Study)].
    Nervenarzt; 1995 Aug; 66(8 Suppl):1-8. PubMed ID: 9131091
    [No Abstract]   [Full Text] [Related]  

  • 8. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial.
    Bluhmki E; Chamorro A; Dávalos A; Machnig T; Sauce C; Wahlgren N; Wardlaw J; Hacke W
    Lancet Neurol; 2009 Dec; 8(12):1095-102. PubMed ID: 19850525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteplase: new indication. Inadequately assessed in ischaemic stroke.
    Prescrire Int; 2004 Aug; 13(72):127-31. PubMed ID: 15532135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition of European Cooperative Acute Stroke Study III results to clinical practice: ninety-day outcomes in a US cohort.
    Cronin CA; Langenberg P; Dutta TM; Kittner SJ
    Stroke; 2013 Dec; 44(12):3544-6. PubMed ID: 24092551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolytic therapy for acute stroke: the Spanish experience. ECASS-II Spanish Group.
    Dávalos A
    Cerebrovasc Dis; 1999; 9 Suppl 3():9-15. PubMed ID: 10436320
    [No Abstract]   [Full Text] [Related]  

  • 14. TPA for acute ischemic stroke.
    Fischer J
    S D J Med; 1997 Feb; 50(2):69-70. PubMed ID: 9062450
    [No Abstract]   [Full Text] [Related]  

  • 15. Stroke busters. New treatments in the fight against 'brain attacks'.
    Schrof JM
    US News World Rep; 1999 Mar; 126(10):62-4, 68. PubMed ID: 10346396
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombolysis in acute ischemic stroke.
    Lang W; Domanovits H; Görzer H; Germann P; Gatterbauer E; Segall B
    Acta Anaesthesiol Scand Suppl; 1997; 111():34-7. PubMed ID: 9420947
    [No Abstract]   [Full Text] [Related]  

  • 17. Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis.
    Strbian D; Sairanen T; Meretoja A; Pitkäniemi J; Putaala J; Salonen O; Silvennoinen H; Kaste M; Tatlisumak T;
    Neurology; 2011 Jul; 77(4):341-8. PubMed ID: 21715707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke: the neurological emergency.
    Bogousslavsky J
    Curr Opin Neurol; 1999 Feb; 12(1):45. PubMed ID: 10097884
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and Efficacy of Intravenous Low-Dose Alteplase in Relative Contraindication Patients with Acute Ischemic Stroke.
    Ohta T; Okada K; Fukuda M; Masahira N; Matsuoka T; Tsuno T; Takemura M
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1844-1851. PubMed ID: 29555402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial.
    Davis SM; Donnan GA; Parsons MW; Levi C; Butcher KS; Peeters A; Barber PA; Bladin C; De Silva DA; Byrnes G; Chalk JB; Fink JN; Kimber TE; Schultz D; Hand PJ; Frayne J; Hankey G; Muir K; Gerraty R; Tress BM; Desmond PM;
    Lancet Neurol; 2008 Apr; 7(4):299-309. PubMed ID: 18296121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.